Mannose-Binding Lectin Haplotypes and Infection Risk
Mannose-Binding Lectin Haplotypes and Infection Risk
批准号:
6793437
负责人:
JOHN E LANDERS
金额:
$12.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2004-10-31
关键词:
DNAcomplementdiagnostic testsdisease /disorder proneness /riskgene expressiongenetic susceptibilitygenotypehigh throughput technologyhuman genetic material tagimmune responseinfectionlectinmannoseoligonucleotidesopsoninpolymerase chain reactionselectinssingle nucleotide polymorphismtechnology /technique development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mannose-binding lectin (MBL) plays an important role in the innate immune response via its ability to recognize sugar moieties on the surfaces of a great variety of pathogens. MBL binding leads to destruction by opsonization and/or activation of the complement pathway in an antibody-independent manner. Thus, MBL deficiency has been associated with numerous immune-related diseases including rheumatoid arthritis, systemic lupus erythematosus, and severe infections in children and immunocompromised adults. In addition, the progression of several diseases, including cystic fibrosis, hepatitis BIC and HIV, are also associated with MBL expression. The transcription and functional activity of MBL depend upon polymorphisms within the gene and their phase or haplotypic configuration. Therefore, the ability to easily and inexpensively determine an individual's MBL haplotype would help establish a stronger link between MBL and disease susceptibility and progression, and aid in the development of a diagnostic test. This Phase I proposal applies PolyGenyx's novel molecular SNP haplotyping approach to developing a highthroughput assay for 12 polymorphisms within the MBL gene. Currently, no other method allows simple, reliable, accurate high-throughput haplotyping of SNP loci. Phase II studies are expected to associate an individual's MBL haplotype with risk of infection.
Due to the wide variety of diseases influenced by MBL, the potential commercial applications for a haplotyping assay are diverse and economically attractive. For instance, the annual economic impact of rheumatoid arthritis is estimated at $15B in direct medical costs and $60B in indirect costs. For each disease, evaluating the patient's MBL status would be extremely beneficial. Patients with a haplotypic configuration predicting increased risk of disease/infection could undergo several steps to reduce this risk, improve their quality of life, and reduce the total economic impact to society.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comprehensive Harmonization and Analysis of Case/Control Whole Genome Sequencing Data from the ALS/FTD Compute Project
-
批准号:10592917
-
项目类别:
-
资助金额:$163.03万
-
财政年份:2023
-
负责人:JOHN E LANDERS
-
依托单位:
Identification of genes causative for familial ALS gene using exome sequencing
-
批准号:8628195
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2011
-
负责人:JOHN E LANDERS
-
依托单位:
Identification of genes causative for familial ALS gene using exome sequencing
-
批准号:8433440
-
项目类别:
-
资助金额:$34.73万
-
财政年份:2011
-
负责人:JOHN E LANDERS
-
依托单位:
Identification of genes causative for familial ALS gene using exome sequencing
-
批准号:8086646
-
项目类别:
-
资助金额:$35.98万
-
财政年份:2011
-
负责人:JOHN E LANDERS
-
依托单位:
Identification and Characterization of ALS/FTD Associated Variants Using Whole Genome Sequencing
-
批准号:10216070
-
项目类别:
-
资助金额:$58.63万
-
财政年份:2011
-
负责人:JOHN E LANDERS
-
依托单位:
Identification of genes causative for familial ALS gene using exome sequencing
-
批准号:8296297
-
项目类别:
-
资助金额:$35.98万
-
财政年份:2011
-
负责人:JOHN E LANDERS
-
依托单位:
Characterization of KIFAP3, a Modifier of Survival in Sporadic ALS
-
批准号:8233455
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2010
-
负责人:JOHN E LANDERS
-
依托单位:
Characterization of KIFAP3, a Modifier of Survival in Sporadic ALS
-
批准号:7889905
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2010
-
负责人:JOHN E LANDERS
-
依托单位:
Characterization of KIFAP3, a Modifier of Survival in Sporadic ALS
-
批准号:8056035
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2010
-
负责人:JOHN E LANDERS
-
依托单位:
Characterization of KIFAP3, a Modifier of Survival in Sporadic ALS
-
批准号:8433438
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2010
-
负责人:JOHN E LANDERS
-
依托单位:
An Innovative, High-Throughput Method of SNP Haplotyping
-
批准号:6443703
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:JOHN E LANDERS
-
依托单位:
An Innovative, High-Throughput Method of SNP Haplotyping
-
批准号:6641045
-
项目类别:
-
资助金额:$62.67万
-
财政年份:2000
-
负责人:JOHN E LANDERS
-
依托单位:
An Innovative, High-Throughput Method of SNP Haplotyping
-
批准号:6741450
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2000
-
负责人:JOHN E LANDERS
-
依托单位:
ISOLATION OF THE TWO NONSMALL LUNG CANCER GENES
-
批准号:2882474
-
项目类别:
-
资助金额:$2.69万
-
财政年份:1999
-
负责人:JOHN E LANDERS
-
依托单位:
A SNP-BASED, HIGH-THROUGHPUT, LOW-COST GENOTYPING METHOD
-
批准号:6016622
-
项目类别:
-
资助金额:$12.95万
-
财政年份:1999
-
负责人:JOHN E LANDERS
-
依托单位:
ISOLATION OF THE TWO NONSMALL LUNG CANCER GENES
-
批准号:2717149
-
项目类别:
-
资助金额:$3.02万
-
财政年份:1998
-
负责人:JOHN E LANDERS
-
依托单位:
ISOLATION OF THE TWO NONSMALL LUNG CANCER GENES
-
批准号:2011151
-
项目类别:
-
资助金额:$2.54万
-
财政年份:1997
-
负责人:JOHN E LANDERS
-
依托单位:
国内基金
海外基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:刘宇佳
-
依托单位:
足细胞中补体系统活化以及在足细胞损伤中作用机制研究
-
批准号:81170657
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:丁洁
-
依托单位:
抗单体C反应蛋白抗体在狼疮肾炎中参与补体调理与影响凋亡物质清除的机制研究
-
批准号:81100497
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:谭颖
-
依托单位: